FDA Investigator Christopher D Rush

Christopher D Rush has conducted inspections on 134 sites in 4 countries as of 14 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
134
Last Inspection Date:
14 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Bulgaria, Turkey, Germany
FDA Investigators that have inspected at least one site in common with Christopher D Rush:
Adam C Hipko, Ademola O Daramola, Adrian Rodriguez, Akbar J Zaidi, Alcee M Tavarez, Althea A Williams, Amanda J White, Amy M Oliver, Andrea A Branche, Angela Mock, Anh M Lac, Anya Dlockett Evans, Aqualia L Nelson, Arie R Dyk, Betsy C Galliher, Bing Lin, Blondell W Johnson, Brackens Harris, Brandi E Williams, Brenda G Stewart Munoz, Brian J Ryan, Brian Sanders, Brook Shea, Camille D Brown, Carla A Norris, Cathleen A Castellaw, Charles D Brown, Charles L Larson, Cheneysc, Christopher J Hurst, Christopher K Gibbs, Coleen L Manoy, Connie L Hannon Rabel, Cynthia A Harris, MD, RN, Dallas E Gilbreath Jr, Damaris Y Hernandez, Dana M Lewis, Daniel J Lahar, Daniel S Fam, Danielle Lyke, Danny D Horner, Darla J Christopher, Darryl A Langley, David M Beltran, Decarlos A Gomez, Denicia L Salinas, Denise Connelly, Deniza Karacic, Diana L Ayala, Diane L Raccasi, Edmiston, Edward D Edmiston, Elisa M Fleming, Elmina E Akwo, Elmina E Mboh, Fernando C Martinez, Frans E Mercado, Gilbert Valdez, RS, Glasgow Glasgow, Grant L Davis, Gregory A Holt, Gretchen M Laws, Gwendolyn F Anderson, H Ljamilla Selby, Habacuc V Barrera, Hala L Selby, Haley L Coleman, Hamed Ghoda, Hung V Le, Iris C Macinnes, J Elkins, James H Robinson, James R Fleckenstein, Jamie M Bumpas, Janet B Abt, Janete F Guardia, Janice M Hickok, Jeffrey R Wooley, Jennifer D Young, Jennifer Hua, Jennifer O Dowdy, Jeremy L Stukes, Jeremy W Rotton, Jessica Fierros, RS, Jessica M Simpson, PhD, Joanne M Schlossin, Jodi M Gatica, Joel D Martinez, Johann M Fitch, John T Chapman, Johnson, Jonathan A Womack, José E Meléndez, Jose Martinez, Jr, Joseph E Duran, Juan D Lopez, Jude C Dikes, Kamara Tx, Karen C Daugherty, Karlton T Watson, Kathleen Chmura Shaffer, Kayla R Deatherage, Kelly D Sheppard, Kelly J Pegg, Kenitra D Hewitt, Kevin T Nguyen, Khunnathee Stoner, Kimberly Lewandowski Walker, Kristin N Longfellow, Kunapuli T Madhusudhan, L Grant, Lance Sindo, CIH, CQA, RS, Latorie S Jones, Lauren E Skokan, Leighton Kn Gai, Leonard H Lavi, Lisa M Puttonen, Lisa R Jennings, Lisa R Whitt, Liza L Quiles, Loan T Tran, Lorie S Hannappel, Lourdes R Genera, Maotang Zhou, PhD, Marc R Dickens, Margaret M Annes, Mario Seminara, Martha S Baldwin, Massoud Motamed, Matthew R Maddox, Merelynn Rhoten, Michelle A Krayer, Monique Rac Lester, Monique S Frazier, Nancy S Henley, Nathan D Livers, Navista C Bolton, Nimmy Mathews, Osama A Khatib, Patrice S Hall, Patrick D Stone, MS, Patty P Kaewussdangkul, Paul E Frazier, Pauline N Logan, Peter Kessler, PhD, Philip M Steele, PhD, Phillip D Waldron, Pitman, Ralph H Vocque, Rebecca C O'bryan, Rebecca Co Bryan, Rebecca L Stephany, Rebecca Rodriguez, Renee Johnson, RS, Rhonda L Dash, Rian L Pope, Robert D Tollefsen, Robert T Harris, Robert T Lorenz, Ronda Rloyd Jones, Roy Baby, Saijal P Naik, Sandy J Ziegler, Sara A Valenzuela, Sarah L Fredric, Scott R Nichols, PhD, Scott T Ballard, Sean M Cheney, Seri L Essary, Sha'tina R Alridge, Shanna N Purdy, Shannon A Lowe, Shawn E Larson, Shelby N Turner, Sherrie L Krolczyk, Staci G Mcallister, Stephen D Brown, Stephen L Beekman, Sunitha K Rajaram, PhD, Suzanne N Vallez, Tamera H Hunt, Tamil Arasu, PhD, Tara A Gray, Terri E Gibson, Theresa Kirkham (NMI), Thomas J Arista, Timothy H Vo, Toby Vern H Hill, Torrance J Slayton, Travis M Beard, Travis S Brown, Tricia S Martinez, Trina K Vick, Vilmary Negron Rodriguez, Vivian Garcia, Yaw O Osei, Young M Yoon

Christopher D Rush's Documents

Publish Date Document Type Title
June, 2006 FDA 483 Swiss-American CDMO, LLC - Form 483, 2006-06-27
September, 2003 FDA 483 Response James L Knecht, Do - Form 483R, 2003-10-22
September, 2004 FDA 483 Coats Aloe International, Inc. - Form 483, 2004-09-22
June, 2004 EIR Paul F White, PhD, MD - EIR, 2004-06-07
December, 2004 FDA 483 Revision, Inc - Form 483, 2004-12-02
February, 2006 EIR Allergan Sales, LLC - EIR, 2006-02-21
January, 2007 EIR Sientra, Inc - EIR, 2007-01-11
November, 2005 FDA 483 G & S Instrument Company - Form 483, 2005-11-02
February, 2006 FDA 483 Response Allergan Sales, LLC - Form 483R, 2006-03-06
September, 2004 EIR Coats Aloe International, Inc. - EIR, 2004-09-22
September, 2003 FDA 483 James L Knecht, Do - Form 483, 2003-09-12
April, 2005 EIR Alcon Research, LLC - EIR, 2005-04-13
April, 2004 EIR Advanced Neuromodulation Systems, Inc- Sponsor - EIR, 2004-04-19
December, 2004 FDA 483 AmeriPac, Inc. - Form 483, 2004-12-14
March, 2006 FDA 483 Microconsult, Inc. - Form 483, 2006-03-30
February, 2006 FDA 483 Allergan Sales, LLC - Form 483, 2006-02-21
August, 2005 EIR Abbott Medical - EIR, 2005-08-18
June, 2004 FDA 483 Paul F White, PhD, MD - Form 483, 2004-06-07
September, 2003 EIR James L Knecht, Do - EIR, 2003-09-12
March, 2005 EIR Alcon Research, Ltd. - EIR, 2005-03-10
April, 2004 EIR Insightec, Inc - Sponsor - EIR, 2004-04-01
April, 2005 FDA 483 Alcon Research, LLC - Form 483, 2005-04-13
January, 2007 FDA 483 Sientra, Inc - Form 483, 2007-01-11

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more